You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion

  • Technology appraisal guidance
  • Reference number: TA409
  • Published:  28 September 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • History

On this page

  1. Expected publication
  2. Final appraisal determination
  3. Draft guidance
  4. Invitation to participate
  5. Draft scope documents

History

Documents created during the development process.

Expected publication

  • Equality Impact Assessment (Guidance development) (PDF 169 KB)

    Published:
    28 September 2016

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 301 KB)

    Published:
    24 August 2016
  • Committee papers (PDF 1.82 MB)

    Published:
    24 August 2016
  • Committee papers committee presentation (PDF 678 KB)

    Published:
    24 August 2016

Draft guidance

  • Draft guidance

  • Appraisal consultation document (PDF 294 KB)

    Published:
    08 June 2016
  • Committee papers (PDF 9.65 MB)

    Published:
    08 June 2016
  • Committee papers committee meeting presentation (PDF 1.38 MB)

    Published:
    08 June 2016

Invitation to participate

  • Final scope (PDF 100 KB)

    Published:
    30 November 2015
  • Final matrix (PDF 38 KB)

    Published:
    30 November 2015
  • NICE's response to comments on the draft scope and provisional matrix (PDF 234 KB)

    Published:
    30 November 2015

Draft scope documents

  • Draft scope (pre-referral) April 2015 (PDF 109 KB)

    Published:
    09 October 2015
  • Provisional matrix (pre-referral) April 2015 (PDF 40 KB)

    Published:
    09 October 2015
Back to top